Experience of women with HPV positivity who use vaginal probiotics in order to increase their HPV clearence

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON23151

Enrollment

Registered

2021-02-09

Start date

2021-02-15

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer, HPV clearance

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Women - with HPV positivity - who used > 7 days vaginal probiotics - who can read and write Dutch - with age 18-65 years old

Exclusion criteria

Exclusion criteria: -undergone invasive treatment of the cervix -HSIL who need invasive treatment

Design outcomes

Primary

Measure	Time frame
Willingness to use vaginal probiotics Acceptance treatment duration vaginal probiotics Inconvenience of use	—

Secondary

Measure	Time frame
Therapy compliance Knowledge from patients about their disease Aversion to HPV infections and invasive treatments for cervical cancer	—

Contacts

Public ContactKiki Verkijk

Diakonessenhuis

f.s.verkijk@students.uu.nl0623982927

Outcome results